IRIS Accounts Production v24.2.0.383 07457400 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074574002023-03-31074574002024-03-31074574002023-04-012024-03-31074574002022-03-31074574002022-04-012023-03-31074574002023-03-3107457400ns15:EnglandWales2023-04-012024-03-3107457400ns14:PoundSterling2023-04-012024-03-3107457400ns10:Director12023-04-012024-03-3107457400ns10:Director22023-04-012024-03-3107457400ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107457400ns10:SmallEntities2023-04-012024-03-3107457400ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3107457400ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107457400ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107457400ns10:FullAccounts2023-04-012024-03-310745740012023-04-012024-03-3107457400ns10:RegisteredOffice2023-04-012024-03-3107457400ns5:CurrentFinancialInstruments2024-03-3107457400ns5:CurrentFinancialInstruments2023-03-3107457400ns5:Non-currentFinancialInstruments2024-03-3107457400ns5:Non-currentFinancialInstruments2023-03-3107457400ns5:ShareCapital2024-03-3107457400ns5:ShareCapital2023-03-3107457400ns5:CapitalRedemptionReserve2024-03-3107457400ns5:CapitalRedemptionReserve2023-03-3107457400ns5:RetainedEarningsAccumulatedLosses2024-03-3107457400ns5:RetainedEarningsAccumulatedLosses2023-03-3107457400ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107457400ns5:LeaseholdImprovements2023-04-012024-03-3107457400ns5:PlantMachinery2023-04-012024-03-3107457400ns5:FurnitureFittings2023-04-012024-03-3107457400ns5:ComputerEquipment2023-04-012024-03-3107457400ns5:NetGoodwill2023-03-3107457400ns5:NetGoodwill2024-03-3107457400ns5:NetGoodwill2023-03-3107457400ns5:LeaseholdImprovements2023-03-3107457400ns5:PlantMachinery2023-03-3107457400ns5:FurnitureFittings2023-03-3107457400ns5:ComputerEquipment2023-03-3107457400ns5:LeaseholdImprovements2024-03-3107457400ns5:PlantMachinery2024-03-3107457400ns5:FurnitureFittings2024-03-3107457400ns5:ComputerEquipment2024-03-3107457400ns5:LeaseholdImprovements2023-03-3107457400ns5:PlantMachinery2023-03-3107457400ns5:FurnitureFittings2023-03-3107457400ns5:ComputerEquipment2023-03-3107457400ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3107457400ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 07457400 (England and Wales)









THE TRIANGLE SURGERY LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024






THE TRIANGLE SURGERY LIMITED (REGISTERED NUMBER: 07457400)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


THE TRIANGLE SURGERY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Dr S M Coffey
Dr J H Ford





REGISTERED OFFICE: Station House
North Street
Havant
Hampshire
PO9 1QU





REGISTERED NUMBER: 07457400 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

THE TRIANGLE SURGERY LIMITED (REGISTERED NUMBER: 07457400)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 23,812 32,051
23,812 32,051

CURRENT ASSETS
Stocks 1,200 1,200
Debtors 6 502,741 436,865
Cash at bank and in hand 11,664 3,720
515,605 441,785
CREDITORS
Amounts falling due within one year 7 133,078 105,588
NET CURRENT ASSETS 382,527 336,197
TOTAL ASSETS LESS CURRENT
LIABILITIES

406,339

368,248

CREDITORS
Amounts falling due after more than one
year

8

(14,946

)

(24,837

)

PROVISIONS FOR LIABILITIES (5,459 ) (7,410 )
NET ASSETS 385,934 336,001

CAPITAL AND RESERVES
Called up share capital 2 2
Capital redemption reserve 1 1
Retained earnings 385,931 335,998
SHAREHOLDERS' FUNDS 385,934 336,001

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

THE TRIANGLE SURGERY LIMITED (REGISTERED NUMBER: 07457400)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 August 2024 and were signed on its behalf by:




Dr S M Coffey - Director



Dr J H Ford - Director


THE TRIANGLE SURGERY LIMITED (REGISTERED NUMBER: 07457400)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

The Triangle Surgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 10% on cost
Plant and machinery - 20% on cost
Fixtures and fittings - 20% on reducing balance
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method


THE TRIANGLE SURGERY LIMITED (REGISTERED NUMBER: 07457400)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2023 - 8 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 430,000
AMORTISATION
At 1 April 2023
and 31 March 2024 430,000
NET BOOK VALUE
At 31 March 2024 -
At 31 March 2023 -

THE TRIANGLE SURGERY LIMITED (REGISTERED NUMBER: 07457400)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 April 2023 4,650 44,915 36,879 3,682 90,126
Additions - 2,103 - - 2,103
At 31 March 2024 4,650 47,018 36,879 3,682 92,229
DEPRECIATION
At 1 April 2023 1,395 21,605 31,402 3,673 58,075
Charge for year 465 8,772 1,096 9 10,342
At 31 March 2024 1,860 30,377 32,498 3,682 68,417
NET BOOK VALUE
At 31 March 2024 2,790 16,641 4,381 - 23,812
At 31 March 2023 3,255 23,310 5,477 9 32,051

6. DEBTORS
2024 2023
£    £   
Amounts falling due within one year:
Trade debtors 26,292 16,914
Other debtors 9,981 12,970
36,273 29,884

Amounts falling due after more than one year:
Amounts owed by group undertakings 466,468 406,981

Aggregate amounts 502,741 436,865

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 10,000 15,469
Trade creditors 10,754 2,785
Taxation and social security 103,331 73,391
Other creditors 8,993 13,943
133,078 105,588

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 14,946 24,837

THE TRIANGLE SURGERY LIMITED (REGISTERED NUMBER: 07457400)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

9. ULTIMATE CONTROLLING PARTY

The controlling party is Coffeyford Limited.